CR

Chandra Reddy Ramasubba Reddy Palle

Active Director Director DIN 10632370
DIN 10632370 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Chandra Reddy Ramasubba Reddy Palle

Data last updated:

Chandra Reddy Ramasubba Reddy Palle is a Director at Venrex Pharma Private Limited (since 2024).

DIN 10632370
Primary Designation Director
First Appointment 17 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Venrex Pharma Private Limited U46497TS2024PTC185558
Director17 May 20242024Active

Board colleagues of Chandra Reddy Ramasubba Reddy Palle

NameDINCompanyDesignation
Palle Veera Lakshumma10632371Venrex Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Venrex Pharma Private Limited
Premium access

Shareholding and investment profile for Chandra Reddy Ramasubba Reddy Palle

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Chandra Reddy Ramasubba Reddy Palle

Chandra Reddy Ramasubba Reddy Palle currently holds 1 directorship: Venrex Pharma Private Limited (Director, since 17 May 2024).

Chandra Reddy Ramasubba Reddy Palle was first appointed on 17 May 2024 as Director at Venrex Pharma Private Limited.

The current boards of Chandra Reddy Ramasubba Reddy Palle's companies include Palle Veera Lakshumma (Venrex Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available